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The cardiologist’s main tool for measuring systolic heart failure is left ventricular ejection fraction
(LVEF). Trained cardiologist’s report both a visual and machine-guided measurement of LVEF, but
only use this machine-guided measurement in analysis. We use a Bayesian technique to combine
visual and machine-guided estimates from the PARTNER-IIA Trial, a cohort of patients with aortic
stenosis at moderate risk treated with bioprosthetic aortic valves, and find our combined estimate
reduces measurement errors and improves the association between LVEF and a 1-year composite
endpoint.
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2I. INTRODUCTION
Heart failure (HF) [1–5] remains a leading cause of patient mortality [6–8] and reduced quality of life [9–11]. The
scientific communities’ link between declining left ventricular ejection fraction (LVEF) and a higher probability of
adverse events [12, 13] supports the need for more accurate and reliable methods for measuring LVEF.
While Simpson’s method for measuring LVEF is more accurate than visual estimation, a cardiologist’s visual es-
timate can reduce LVEF variability across patients (increasing reproducibility) by drawing on past experience and
empirical self-correction [14–16]. Previous studies found Simpson’s biplane method reproducible across diverse types
of patients measured by the same echocardiographer, but different echocardiographers and different echocardiographic
tools can draw different conclusions from the same patient [15, 16]. Identifying this extra variability in LVEF mea-
surements can create more robust LVEF estimates and may translate to better patient diagnosis, treatment options,
and prognostic predictions.
We applied a simple Bayesian approach to fuse the more stable cardiologist’s visual LVEF with the more accurate
Simpson’s bi-plane calculated LVEF. This novel assimilated LVEF allows expert opinion and clinical experience to
more directly take part in analysis, reduces the measurement variability in LVEF, and leads to more robust inference
between LVEF and outcomes.
II. METHODS
We studied echocardiographic data collected from the PARTNER-IIA trial [3, 4] which randomized North-American
patients with severe aortic stenosis to either surgical aortic valve replacement (SAVR) or transcatheter aortic valve
replacement (TAVR).
An independent core-lab measured LVEF in 1366 PARTNER-IIA patients using both visual estimation and Simp-
son’s bi-plane method. The visual estimation of LVEF was specified in commonly used intervals of 5% and Simpson’s
biplane method was reported to the first decimal place.
We expressed our uncertainty in a patient’s true LVEF by placing a normal distribution on top of the cardiologist’s
visual LVEF estimate with a 18.1% standard deviation reported from previous work [17]. The next step overlaid a
normal distribution over top of the cardiologist’s measurement of LVEF with Simpson’s biplane method with a 8.8%
standard deviation reported from previous work [18]. Our final step combined both visual and Simpson’s biplane
normal distributions with Bayes theorem.
Mathematically, we approximated a patient’s true LVEF (θ) by combining the visual estimate (V ) with variance
σ[V ] and Simpson’s biplane estimate (S) with variance σ[S] as
p(θ = l|D, σ) ∝ p(S|θ, σ [S])× p(θ|V, σ [V ]) (1)
where D represents the visual LVEF and Simpson’s LVEF data and σ represents the measurement error (or uncer-
tainty) in both LVEF measurements. We updated our visually informed prior, p(θ|V, σ [V ]), with our uncertainty in
Simpson’s biplane measurement, p(S|θ, σ [S]), and expressed our final uncertainty in a patient’s true LVEF as
p(θ|D, σ) ∝ N (θ, σ[θ]) (2)
where N represents a Normal distribution with θ equal to
θ =
σ[V ]S + σ[S]V
σ[V ] + σ[S]
(3)
and σ[θ] equal to
σ[θ] =
1
σ−1[V ] + σ−1[S]
. (4)
We can redefine θ by dividing Simpson’s biplane precision by the visual precision
ω =
σ−1[S]
σ−1[V ]
(5)
and total variation
T = σ[V ] + σ[S]. (6)
3After rewriting θ and σ[θ] in terms of ω and T , we find θ borrows Simpsons biplane accuracy and lies ω times closer
to Simpsons biplane measurement than the visual estimate,
θMAP =
ωS + V
T
(7)
and used the cardiologist’s visual estimate (their experience) to reduce measurement error by
R =
σ[θ]− σ[S]
σ[S]
=
−1
ω + 1
(8)
relative to Simpson’s biplane measurement (Figure 1).
We can build uncertainty around the 18.1% visual LVEF’s measurement error and 8.8% Simpson’s measurement
error to quantify how well this assimilated method reduces measurement error (R). For each measurement error, we
consider a non-informative Gamma-distributed prior and Gamma likelihood. We draw 5×103 parameter samples from
a 2 × 104 long Markov-chain Monte-Carlo chain with Normally distributed proposal for both visual and Simpson’s
measurement error, and from each parameter sample, draw a predictive measurement error. Each pair of (visual,
Simpson) measurement error predictions corresponds to a relative reduction and can quantify our uncertainty in R.
We also applied the above measurement error model to create more robust statistical inferences in time to event anal-
ysis. Our first step draws samples from each patient’s LVEF distribution. This first step represents the measurement-
error step of our model. The next step applies Kaplan-Meier methodology and Cox-proportional hazards model to
predict 1 year death, rehospitalization, and stroke as if each LVEF measurement was exact. The last step compiles
the N test statistics created from the novel assimilated LVEFs predictions to conclude how differences in LVEF affect
the 1-year event rate.
III. RESULTS
The PARTNER-IIA cohort contains 1366 patients with paired visual estimates of LVEF and Simpson’s biplane
measured LVEF, and resembles the overall PARTNER-IIA cohort (Table 2A.). Patients from this paired dataset have
an average Simpsons Ejection Fraction of 55.78% (s.d. 11.37%), moderate LV hypertrophy (mean LV mass index of
120.53 g/m2 [s.d. 32.89 g/m2]), and a reduced aortic valve area (0.69 cm2 [s.d. 0.18 cm2]) coupled with higher mean
gradients (mean gradient 45.29 mmHg [s.d. 12.87 mmHg]). The above results indicate these patients have baseline
characteristics similar to the full cohort of PARTNER-IIA patients [3].
Shifting focus to LVEF, we found no significant difference between Simpson’s biplane LVEF and visual LVEF on
average (Figure 2B). For patients with a visual LVEF under 35%, the average difference between Simpson’s LVEF
and visual LVEF equals 0.93% (s.d. 3.18%). Patients with visual LVEF estimates between 35% and 50% have an
average difference between Simpson’s LVEF and visual LVEF equal to 1.53% (s.d. 3.78%). Patients with normal
LVEF have an average difference between Simpson’s LVEF and visual LVEF of 0.60% (s.d. 4.04%). We find the
maximum difference between Simpson’s LVEF minus visual LVEF equals 24.96%, and minimum difference between
Simpson’s LVEF minus visual LVEF equals -22.56%.
After fusing together the cardiologist’s visual estimate with Simpson’s biplane method, the assimilated LVEF shifted
by +1.34% (s.d. 1.97%) on average compared to the visual LVEF and shifted by -0.65% (s.d. 0.96%) on average
relative to Simpson’s biplane method in patients with a visual LVEF < 35%, shifted by +0.82% (s.d. 2.79%) on
average relative to visual LVEF and shifted by -0.40% (s.d. 1.36%) on average relative to Simpson’s biplane method
in patients with a visual LVEF estimate between 35% and 50%, and shifted by +0.87% (s.d. 2.51%) on average
relative to visual LVEF and by -0.42% (s.d. 1.22%) on average relative to Simpson’s biplane method in patients with
a visual LVEF above 50% (Figure 3).
We also found the assimilated LVEF reduces the population standard deviation (Figure 3) relative to Simpson’s
biplane by 11.24% in patients with visual LVEF < 35%, by 9.96% in patients with visual LVEF between 35% and
50%, and by 13.21% in patients with a visual LVEF above 50%.
We more formally considered our uncertainty in visual and Simpson’s measurement and found the assimilated LVEF
reduced measurement error by -33.55% (95%CI [-58.69%, -13.76%]) on average compared to Simpson’s biplane (Fig-
ure. 4). Our Bayesian model of Simpson’s measurement error placed 95% of the probability mass between 3.35%
and 17.72%, with an average measurement error equal to 8.63%. Our visual measurement error’s Bayesian model
distributed 95% of the probability mass between 8.00% and 34.11%, with an average measurement error equal to
17.68%. The most conservative circumstances still find the assimilated model reduces measurement error compared
to Simpson’s biplane.
We explored the relationship of this novel assimilated LVEF with a composite of death, stroke, and rehospitalization
at to 1 year, and found the strength of association between LVEF and outcome weakest for visually estimated LVEF,
4stronger for Simpson’s biplane method, and strongest for using our assimilated method (Figure 5). The visually
estimated LVEF measurements show the most variability with Kaplan-Meier’s 95% credible intervals overlapping
throughout the full 365 days (Figure 5A). At one year, the event rate for patients with visually estimated LVEF
< 35% was 16.35% (95% CI [13.08%, 19.61%]), for patients with visually estimated LVEF between 35% and 50%
was 14.97% (95%CI [11.91%, 18.02%]), and for patients with visually estimated LVEF > 50% was 14.68% (95%CI
[13.45%, 15.89%]).
We find smaller variability and more separation between patient groups classified by LVEF with Simpson’s biplane
method (Figure 5B). At one year, the event rate for patients with Simpson’s biplane estimated LVEF < 35% equals
18.94% (95%CI [14.98%, 22.96%]), for patients with Simpson’s biplane estimated LVEF between 35% and 50% equals
14.81% (95% CI [12.13%, 17.60%]), and for patients with Simpson’s biplane estimated LVEF > 50% equals 14.62%
(95%CI [13.83%, 15.39%]).
After we combine the cardiologist’s visual LVEF with Simpson’s LVEF measurement, we see the median failure
rates moving closer together contrasted by a reduction in error bounds (Figure 5C). At 1-year, the event rate for
patients with an assimilated LVEF < 35% equals 19.90% (95%CI [17.75%, 22.30%]), for patients with an assimilated
LVEF between 35% and 50% equals 14.14% (95%CI [12.44%, 15.85%]), and for patients with an assimilated LVEF >
50% equal 14.75% (95%CI [14.42%, 15.08%]).
Compared to the visual LVEF measurement and Simpson’s bi-plane measurement, the assimilated method pushed
the LVEF patient group’s average Kaplan-Meier estimate up and pulled the LVEF patient group’s average Kaplan-
Meier estimate down while at the same time reducing the estimate’s overall variability (Figure 5).
The assimilated LVEF’s hazard ratio relates decreasing LVEF and increasing hazards of 1-year death, stroke, and
rehospitalization more confidently than Simpson’s or visually estimated LVEF (Figure 6). We find a 5% increase
in assimilated LVEF corresponds to a 1.079 (95%CI [1.070, 1.087]) hazard ratio, in Simpson’s LVEF corresponds
to a 1.052 (95%CI [1.029, 1.074]) hazard ratio, and in visual LVEF corresponds to a 1.021 (95%CI [0.999, 1.044])
hazard ratio. The assimilated LVEF’s smaller credible interval represents a more certain and reproducible relationship
between LVEF and 1-year death, stroke, and rehospitalization.
IV. DISCUSSION
After combining the visually estimated LVEF, honed through years of training, with Simpson’s method, derived
from a simple LVEF tracing from apical views, we find this novel assimilated LVEF reduces measurement error,
improves reproducibility, and better predicts hard clinical events at 1 year.
This study highlights the important role of reducing variability when measuring the most common clinical currency
in heart disease - LVEF. Combining the visual estimate and Simpson’s biplane measurement blends the cardiologist’s
established expertise with accurate image analysis and outperforms simpler LVEF metrics.
In daily echocardiography practice, we unrealistically assume all physicians produce equal quality echo images.
Similar to assuming equal image quality, we do not adjust LVEF values for differing levels of experience / echocar-
diographic expertise. Differing image quality and echocardiographic expertise could play a major role in visual LVEF
and Simpson’s biplane LVEF measurement accuracy.
This assimilated LVEF may prove useful in the presence of poor echocardiographic images, where the cardiologist’s
visual estimate can more accurately judge LVEF. Upcoming work will investigate how qualitative measurements of
image quality affect visual LVEF measurement and Simpson’s LVEF measurement.
We also aim to develop more sophisticated statistical models that further reduce measurement error. Focusing on
a single noisy variable allowed us to demonstrate the importance of noise, but we will expand our work to study
multiple covariates under measurement error and how this affects their associations with outcomes. As far as we
know, small measurement errors do not alter associations between covariates, but we will explore whether many small
measurement errors across many covariates can change relationships between variables.
We acknowledge several limitations for this study. The cohort we studied was a subset of patients from the entire
trial, though this subset did not differ in baseline characteristics from the overall cohort. This analysis was not
pre-specified and suffers from the same limitations of any retrospective analyses. The estimates for LVEF variability
depended on small samples from previous studies and needs more data to better estimate interobserver variability.
This work aspires toward a more robust way to study relationships between clinical measurements and outcomes,
reduce measurement error, and shows the cardiologist’s intuition (derived from years of experience and iterative
self-correction) remains a valuable tool.
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FIG. 1. We combine a patient’s visual LVEF and Simpson’s biplane LVEF measurements for a more assured estimate of a
patient’s true LVEF. This assimilated LVEF measurement draws accuracy from Simpsons biplane LVEF and consistency from
the visual LVEF to reduce measurement error.
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Number of patients analyzed∗ (1366/2029)
Population characteristics
Age (yrs) 82.14 (6.38)
BMI (kg/m2) 27.60 (5.54)
BSA (m2) 1.85 (0.23)
Diabetes 33.88 (453/1337)
Prior CABG 21.62 (289/1337)
Prior PCI 26.40 (353/1337)
Echocardiography
LVEF 55.78 (11.37)
Visual (p) 54.45 (10.84)
Simpson’s bi-plane (p) 55.78 (11.37)
Cardiac Output (L/min) 3.65 (1.16)
Stroke Volume (mL) 29.90 (8.34)
Heart Rate (bpm) 71.46 (12.57)
LV Mass index (g/m2) 120.53 (32.89)
LAV Index∗∗∗ (mL/m2) 40.96 (13.38)
E/e’ Medial 21.02 (9.82)
LV End Systolic Volume (mL) 48.41 (29.92)
LV End Diastolic Volume (mL) 103.89 (39.67)
LVOT Peak Velocity (cm/s) 93.47 (19.48)
Aortic Annulus Diameter (cm) 3.26 (0.39)
Mean Gradient (mmHg) 45.29 (12.87)
Aortic Valve Area (cm2) 0.69 (0.18)
* We study patients with visual LVEF and Simpson’s bi-plane LVEF measurements
** Left Ventricular Outflow Tract
*** Left Atrium Volume Index
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FIG. 2. Patients with paired visual and Simpson’s biplane estimates present the same clinical picture as PARTNER-IIA
patients, and cardiologists took unbiased and agreeable LVEF measurements. (A) We report averages and standard deviation
inside parentheses. Similar to PARTNER-IIA’s ITT population, patients show signs of decreased heart function (low Cardiac
output and small aortic diameter) and compensatory mechanisms (high LV mass). (B) For each of the 1366 patients with paired
LVEF data, we plot the difference between Simpson’s biplane method and the cardiologist’s visual estimate versus the average
LVEF (〈L〉) between the two methods. Stratifying by an average LVEF, we find good agreement between Simpons biplane
and visual estimates with an average difference of 0.93% (s.d. 3.18%) for 〈L〉 < 35%, 1.53% (s.d. 3.78%) for 〈L〉 between 35%
and 50%, and 1.53% (s.d. 3.78%) for 〈L〉 > 50%. Patients with paired data resemble the PARTNER-IIA population making
this a realistic population to find in practice and show good agreement between Simpsons biplane LVEF and the visual LVEF
independent of average LVEF.
9FIG. 3. The assimilated LVEF achieves a population wide LVEF that lies closer to the more accurate Simpson’s biplane
method and with smaller variability than either visual or Simpson’s biplane estimates of LVEF. We draw boxplots for each
LVEF estimate method (visual, Simpson’s biplane, and assimilated) stratified by visual LVEF below 35%, LVEF between 35%
and 50%, and LVEF above 50%. Across strata, the assimilated median LVEF lies above the median visual LVEF and below
Simpsons biplane LVEF, and shrinks the interquartile range (length of boxes) compared to Simpson’s biplane method.
10
FIG. 4. Compared to Simpson’s biplane and considering our estimates of measurement error uncertain, our assimilated LVEF
has an average -33.55% (95%CI[-58.69%, -13.76%]) relative reduction. This decrease in measurement error will lead to more
clearly classifying patient with heart failure and more powerful statistical conclusions.
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FIG. 5. We quantify the impact of measurement error on the association between LVEF and 1 year death, stroke, and
rehospitalization by (i) cutting the population into three groups based on visual LVEF, Simpson’s biplane LVEF, and assimilated
LVEF, (ii) estimating Kaplan-Meier event rates, and (iii) shading the event rates 95% credible interval based on uncertainty
in each patient’s LVEF estimate. (A) Stratifying by visual LVEF shows minor differences between LVEF categories. (B) The
average Kaplan-Meier curve’s shape for patients stratified by Simpsons biplane LVEF resembles the visual Kaplan-Meier curve,
but has smaller credible intervals. LVEF measured by Simpson’s biplane increased precision and reduced measurement error
enough to draw statistical conclusions about patients with LVEF < 35%. (C) The assimilated LVEF shrinks credible intervals
the most compared to visual or Simpson’s biplane LVEF, and smaller credible intervals among strata translates to stronger
conclusions about the association between LVEF and outcomes.
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FIG. 6. Estimated hazard ratios for a 5% decrease in assimilated, Simpson’s, and visual LVEF’s impact on 1-year Death,
stroke, and rehospitalization. We find the weakest association between visual LVEF and the 1-year endpoint (HR [95%CI] =
1.021 [0.999, 1.044]), a stronger association between Simpson’s LVEF and the 1-year endpoint (HR [95%CI] = 1.052 [1.029,
1.074]), and the most consistent association between assimilated LVEF and the 1-year endpoint (HR [95%CI] = 1.079 [1.070,
1.087]). The assimilated LVEF develops a more reproducible association with clinical endpoints.
